Latvijas Biomedicīnas pētījumu un studiju centrs Overview

  • Founded
  • 1993
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Latvijas Biomedicīnas pētījumu un studiju centrs General Information

Description

Developer of medical services designed for molecular and cell biology research. The company's services are engaged in both fundamental and translational research in various areas of biomedicine, which can give competent consultations as well as give technical support for various research activities on human genetics and disease mechanisms, cancer research, biotechnology and structural biology, molecular microbiology and virology, molecular pharmacology and drug targets, enabling researchers of other institutions to avail this service.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Primary Office
  • 1 Rātsupītes Street
  • Riga, LV-1067
  • Latvia
+371 67 000 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Latvijas Biomedicīnas pētījumu un studiju centrs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view Latvijas Biomedicīnas pētījumu un studiju centrs’s complete valuation and funding history, request access »

Latvijas Biomedicīnas pētījumu un studiju centrs Executive Team (1)

Name Title Board Seat Contact Info
Janis Klovins Director
To view Latvijas Biomedicīnas pētījumu un studiju centrs’s complete executive team members history, request access »

Latvijas Biomedicīnas pētījumu un studiju centrs Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accelerace Accelerator/Incubator Minority 000 0000 000000 0
To view Latvijas Biomedicīnas pētījumu un studiju centrs’s complete investors history, request access »